Radiation Dermatitis Market: Introduction
According to the report, the global radiation dermatitis market was valued at ~US$ 400 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. The International Agency for Research on Cancer (IARC) states that the number of new cancer cases is likely to rise to 19.3 million, with 10 million cancer deaths in 2020. This indicates one in 5 people develop cancer during their lifetime, and one in 8 men and one in 11 women succumb to the disease. According to statistics presented by the American Society for Radiation Oncology, nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, whereas 85% of the total patient base experience severe to moderate radiation dermatitis that requires intensive treatment. This is expected to propel the global radiation dermatitis market.
Request a Sample of Radiation Dermatitis Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=81522
Asia Pacific dominated the global radiation dermatitis market in 2019 and the trend is anticipated to continue during the forecast period. The rise in population suffering from cancer in Asia Pacific has increased the number of patients opting for radiation therapy. Hence, the usage of radiation dermatitis treatment products is expected to increase during the forecast period. Asia Pacific is likely to be a highly lucrative market for radiation dermatitis treatment from 2020 to 2030. The market in the region is projected to expand at a high CAGR during the forecast period.
Enquiry Before Buying Radiation Dermatitis Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=81522
Rise in Prevalence of Cancer to Drive Market
According to the WHO, cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women. The rate of certain types of cancer such as breast and head & neck is projected to increase in the near future. This can be attributed to faulty lifestyle factors such as obesity for breast cancer and smoking for head & neck cancers. Moreover, cancers mentioned above are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall rise in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the global radiation dermatitis market.
Request For Discount – https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=81522
Topical Agents to Dominate Global Market
In terms of product, the global radiation dermatitis market has been classified into oral medication, topical, and dressings. The topical segment dominated the global radiation dermatitis market in 2019 and the trend is projected to continue during the forecast period. The growth of the segment can be attributed to the fact that topical agents are the most prescribed products in the radiation dermatitis treatment market, especially hydrophilic creams and corticosteroids. Hydrophilic creams are extensively used across the globe, as these provide hydration and soothing relief from itching, and other symptoms of radiation dermatitis.
Buy now Radiation Dermatitis Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=81522<ype=S
Retail Pharmacies to be Major Distribution Channel
Based on distribution channel, the global radiation dermatitis market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the global radiation dermatitis market and the trend is anticipated to continue during the forecast period. Radiation dermatitis can develop either during or even several months after radiation therapy. Hence, a retail pharmacy is likely to be driven by patients who are referred to purchase particular products by peer recommendation. Additionally, it is driven by proximity to local area and familiarity of use by loyal customers.
Competition Landscape
Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.
More Trending Reports by Transparency Market Research:
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of analysts, researchers, and consultants who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
